Suppr超能文献

鼻型结外NK/T细胞淋巴瘤中频繁出现的BCOR畸变。

Frequent BCOR aberrations in extranodal NK/T-Cell lymphoma, nasal type.

作者信息

Dobashi Akito, Tsuyama Naoko, Asaka Reimi, Togashi Yuki, Ueda Kyoko, Sakata Seiji, Baba Satoko, Sakamoto Kana, Hatake Kiyohiko, Takeuchi Kengo

机构信息

Pathology Project for Molecular Targets, The Cancer Institute, Japanese Foundation for Cancer Research, Koto, Tokyo.

Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Koto, Tokyo.

出版信息

Genes Chromosomes Cancer. 2016 May;55(5):460-71. doi: 10.1002/gcc.22348. Epub 2016 Feb 10.

Abstract

Extranodal natural killer/T cell lymphoma (ENKTL) is a rare subtype of lymphoma. Recurrent mutations in the JAK-STAT pathway, recently reported in ENKTL cases, are interesting in terms of both pathogenesis and inhibitor therapy. However, the frequencies of these mutations are low and variable among reports, and other pathognomonic mutations in ENKTL remain to be elucidated. In the present study, targeted capture sequencing of 602 cancer-related genes from 25 frozen ENKTL samples was performed, 11 of which were matched to normal samples. Several recurrent somatic mutations involving BCOR (32%), TP53 (16%), DDX3X (12%), FAT4 (8%), NRAS (8%), MLL3 (12%), and MIR17HG (8%) were identified. The pattern of BCOR aberrations (1 nonsense and 5 frame-shift mutations, a mutation leading to a splicing error, and gene loss) suggested that loss of function of BCOR was the functionally important outcome of such changes. The literature was reviewed and the public data on BCOR aberrations was reanalyzed and it was found that the aberrations were frequently found in myeloid neoplasms, but, interestingly, were highly specific to ENKTL among lymphoid malignancies. Given the high frequency and pattern of aberration, BCOR is likely to play an important role in ENKTL pathogenesis as a tumor suppressor gene.

摘要

结外自然杀伤/T细胞淋巴瘤(ENKTL)是淋巴瘤的一种罕见亚型。近期在ENKTL病例中报道的JAK-STAT通路复发性突变,在发病机制和抑制剂治疗方面都很有意思。然而,这些突变的频率较低且各报告之间存在差异,ENKTL的其他特征性突变仍有待阐明。在本研究中,对25份冷冻的ENKTL样本进行了602个癌症相关基因的靶向捕获测序,其中11份样本与正常样本匹配。鉴定出了几处涉及BCOR(32%)、TP53(16%)、DDX3X(12%)、FAT4(8%)、NRAS(8%)、MLL3(12%)和MIR17HG(8%)的复发性体细胞突变。BCOR畸变模式(1个无义突变和5个移码突变、1个导致剪接错误的突变以及基因缺失)表明,BCOR功能丧失是此类变化在功能上的重要结果。对文献进行了综述,并对关于BCOR畸变的公共数据进行了重新分析,发现这些畸变在髓系肿瘤中经常出现,但有趣的是,在淋巴恶性肿瘤中对ENKTL具有高度特异性。鉴于畸变的高频率和模式,BCOR作为一种肿瘤抑制基因可能在ENKTL发病机制中发挥重要作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验